|
REST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.55020000064599E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21419999610239E-08 |
| Normal-vs-Stage2 |
1.155790E-04 |
| Normal-vs-Stage3 |
7.320500E-03 |
| Normal-vs-Stage4 |
3.649500E-04 |
| Stage1-vs-Stage2 |
7.979200E-01 |
| Stage1-vs-Stage3 |
3.329800E-01 |
| Stage1-vs-Stage4 |
7.211400E-01 |
| Stage2-vs-Stage3 |
6.376200E-01 |
| Stage2-vs-Stage4 |
6.126000E-01 |
| Stage3-vs-Stage4 |
4.509000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75880000458295E-08 |
| Normal-vs-AfricanAmerican |
1.33370000043875E-07 |
| Normal-vs-Asian |
3.232100E-04 |
| Caucasian-vs-AfricanAmerican |
5.758400E-01 |
| Caucasian-vs-Asian |
4.778800E-01 |
| AfricanAmerican-vs-Asian |
4.994800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.50920004166255E-09 |
| Normal-vs-Female |
1.055520E-02 |
| Male-vs-Female |
1.723990E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.53279999999256E-05 |
| Normal-vs-Extreme_Weight |
3.0642999249153E-10 |
| Normal-vs-Obese |
8.04229999999961E-05 |
| Normal-vs-Extreme_Obese |
5.50029999999424E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.478600E-01 |
| Normal_Weight-vs-Obese |
3.317400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.402600E-01 |
| Extreme_Weight-vs-Obese |
1.423890E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.559200E-01 |
| Obese-vs-Extreme_Obese |
2.820400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.780300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.35189999999719E-05 |
| Normal-vs-Age(61-80Yrs) |
8.08609956770567E-10 |
| Normal-vs-Age(81-100Yrs) |
1.80130000027034E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.313800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.413450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.009900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.413850E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.796600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.847000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.97479996191896E-09 |
| Normal-VS-Type2 PRCC |
1.30270000009425E-07 |
| Normal-VS-KIRP CIMP |
3.765400E-01 |
| Normal-VS-Unclassified PRCC |
4.923900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.859600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.952100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.918000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.301200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.383700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.632600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.91739957244863E-10 |
| Normal-vs-N1 |
6.882900E-03 |
| Normal-vs-N2 |
1.553780E-02 |
| N0-vs-N1 |
1.008550E-01 |
| N0-vs-N2 |
7.333000E-01 |
| N1-vs-N2 |
6.398600E-01 |
|
|
